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Cognitive rehabilitation treatment for mental 
slowness in conversion disorder: A case report
L. de Vroege1,2*, D. Khasho2, A. Foruz2 and C.M. van der Feltz-Cornelis1,2
Abstract: Cognitive rehabilitation treatment (CRT) has been described in patients 
with brain injury, but it has not been attempted in cases of cognitive dysfunction 
without organic cause. This case report describes CRT of neurocognitive impairment 
in a 54-year-old female patient with conversion disorder (CD). She experienced dif-
iculties with regard to speaking, motor function, and pain symptoms, which de-
veloped after stressful life circumstances. Baseline neuropsychological assessment 
(NPA) showed mental slowness and impaired (working) memory. Time Pressure 
Management (TPM) was used as CRT to teach the patient a compensatory strategy 
to overcome mental slowness in 12 sessions. During treatment, physical symp-
toms were monitored with the Physical Symptom Questionnaire (LKV), and mental 
slowness with the Mental Slowness Questionnaire (MSQ). After treatment, the LKV 
score dropped from 85 to 47, indicating 54% treatment response. Mental slowness 
showed improvement based on the MSQ and was conirmed by an NPA after treat-
ment. Other neurocognitive functions improved as well and the motoric CD symp-
toms subsided. This case report suggests that improvement of mental slowness, as 
well as motor CD symptoms, can be achieved by TPM in non-organic neurocogni-
tive impairment in CD. This inding has not been described in the literature. Further 
research is warranted to explore the eicacy of TPM in CD.
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1. Introduction
Conversion disorder (CD), as stated in the Diagnostic and Statistical Manual of Mental Disorder 
(DSM)-V (American Psychiatric Association, [APA], 2013), includes one or more deicits afecting ei-
ther motor or sensory function, that are incompatible with clinically recognized neurological or med-
ical conditions, that cannot be explained by any other medical or mental disorder and cause clinically 
signiicant distress or impairment in occupational, social, or other important areas of functioning. 
The symptoms or deicits can be a sense of weakness or paralysis, abnormal movement (e.g. tremor 
or myoclonus), swallowing or speech symptoms, seizure-like attacks, memory loss or anesthesia, 
and special sensory symptoms or mixed symptoms. CD can exist with or without a psychological 
stressor and is considered persistent if symptoms are present for over six months.
Treatment interventions for CD have been scarcely evaluated in Randomised Controlled Trials 
(RCT) so far, although a Cochrane Review in 2005 (Ruddy & House, 2005) that found insuicient evi-
dence for psychosocial interventions in CD stated that randomized studies are possible in this ield. 
Kroenke stated in 2007 that evidence for the efectiveness of interventions in CD was lacking, with 
two RCTs evaluating the efect of hypnosis showing limited results (Kroenke, 2007). A systematic 
review evaluating the efectiveness of a drug interview in the treatment of CD concluded that al-
though there were some indications of a possible positive efect, especially in the use of suggestion 
and the occurrence of emotional catharsis during the interview, the research was of poor quality 
(Poole, Wuerz, & Agrawal, 2010). Two systematic reviews of the efects of physiotherapy found no 
RCT establishing its efectiveness in adults (Nielsen, Stone, & Edwards, 2013) or children with CD 
(FitzGerald, Southby, Haines, Hough, & Skinner, 2015). Despite this lack of evidence, clinical practice 
for CD has so far included multidisciplinary treatment, including psychosocial interventions and 
physiotherapy and sometimes suggestion or hypnosis. Therefore, there is certainly room for im-
provement and a need for new treatment modes for CD. A candidate for such an innovative ap-
proach might be focusing on the cognitive impairments in CD, as motor functions require adequate 
cognitive functioning, especially in terms of planning.
So far, studies exploring cognition in CD have reported impairment of executive function (EF) in 
combination with memory impairment (Brown, Nicholson, Aybek, Kanaan, & David, 2013; Kozlowska 
et al., 2015) or impaired visuospatial function, memory, and attention (Demir, Celikel, Taycan, & 
Etikan, 2013; Kozlowska et al., 2015), or standalone memory impairment (Fargo et al., 2004). There 
are a limited number of studies exploring cognition in CD. Moreover, the studies at hand examined a 
selection of neurocognitive functions, which precludes the possibility of drawing conclusions on 
whether impaired memory is caused by mental slowness or solely an impairment of verbal memory. 
This is a major limitation within the present literature. Furthermore, a variety of tests conducted by 
diferent studies result in ambiguous and inconsistent indings with regard to neurocognitive impair-
ment in CD. The role of neurocognitive impairment in CD has received too little research attention, 
and this is of clinical relevance in view of developing possible treatment options for cognitive impair-
ment in CD, such as cognitive rehabilitation treatment (CRT).
CRT is already used in patients who sufer from cognitive impairment due to stroke or traumatic 
brain injury. Common symptoms after stroke and traumatic brain injury include mental slowness 
(Ballard et al., 2003; Gerritsen, Berg, Deelman, Visser-Keizer, & Jong, 2003) that may lead to fatigue 
and altered mood (Hochstenbach, Mulder, van Limbeek, Donders, & Schoonderwaldt, 1998; Rasquin, 
Lodder, Ponds, Winkens, & Jolles, 2004). A CRT that has been proven beneicial for mental slowness 
in stroke patients (Winkens, van Heugten, Wade, Habets, & Fasotti, 2009) is Time Pressure 
Management (TPM) (Fasotti, Kovacs, Eling, & Brouwer, 2000).
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TPM involves a cognitive strategy that compensates for the consequences of mental slowness in 
daily life (e.g. preparing a meal or during conversations). The essence of TPM is that patients allow 
themselves to take the time needed to deal with tasks. In that sense, TPM leads to retraining or ac-
quiring compensatory strategies so that neurocognitive symptoms can be reduced (Ben-Yishay & 
Diller, 1993). However, the efect of CRT in general, or TPM in particular, as a treatment option for 
neurocognitive impairment in CD has not yet been explored.
The application of CRT to a speciic neurocognitive symptom, as in TPM, enables a clinician to tailor 
treatment speciically to the patients’ neuropsychological proile. Laatsch and Stress (2000) de-
scribed how treatment outcomes can be maximized in patients with stroke or traumatic brain injury 
by taking into account and focusing on neurocognitive symptoms. Such an approach in patients with 
CD warrants a description of neurocognitive symptoms of patients with CD but studies exploring 
these symptoms are limited in number. However, patients do present themselves with neurocogni-
tive impairment in clinical practice. One can thus argue that they might beneit from CRT tailored to 
resolve the speciic impairment found by neuropsychological assessment (NPA). However, the ap-
plicability and efect of CRT in CD has not been studied. This case report aims to do so.
In this case report, we describe a 54-year-old woman with severe neurocognitive symptoms who 
presented herself at our clinic in 2013. Her symptoms had developed since an episode in 2010 in 
which she had presented herself at a neurology department with Transient Ischemic Attack (TIA) 
like symptoms that were deemed psychogenic after neurological assessment, including magnetic 
resonance imaging (MRI). She was diagnosed with CD and received treatment for her neurocognitive 
symptoms in our outpatient clinic with good results. This case report (a) supports the use of NPA in 
patients with CD for assessing neurocognitive impairment, followed by selecting a itting CRT, (b) 
presents preliminary evidence that the severity of mental disorders dissolves after TPM, and (c) 
shows that the opportunity to evaluate and treat neurocognitive symptoms in CD should be further 
explored in future controlled research.
2. Case report
2.1. History
A 54-year-old woman (JH), living alone and working in a health care facility under stressful condi-
tions which led to fatigue and heart palpitations, was threatened by a patient during her work. The 
day after that, JH started to experience blurred vision. She thought this blurry vision was a result of 
the stress she experienced at work. The next morning, she experienced tingling feelings in the left 
side of her face, left arm, and leg. She also noticed her face was drooping to the left, the left side of 
her tongue felt numb, and she had started to slur her speech and stutter. She presented herself with 
these symptoms to a neurological clinic. JH reported that she had already experienced daily head-
aches and pain in the neck before the event, but that this pain had increased. Subjective neurocogni-
tive symptoms, mainly memory problems, trouble concentrating, and participating in conversations, 
which resulted in the experience of increased headache, were present at the neurologic assessment 
as well. Neurological assessment for TIA showed a normal brain computerized tomography (CT) 
scan, brain nerves, and electrocardiogram (sinus rhythm). Doppler of carotid arteries revealed no 
abnormalities. An MRI to rule out stroke showed no underlying pathological explanation for the 
symptoms. The neurologist concluded that the symptoms were psychogenic and referred JH to a 
psychologist and physiotherapist for treatment. After check-up, two months later, speaking had 
improved. The psychologist concluded that JH’s symptoms could be explained by prolonged expo-
sure to stress at work, which had led to overburdening. The neurocognitive symptoms were still 
present, for which JH requested further examination. The MRI was repeated but again showed no 
abnormalities. NPA was suggested by the neurologist, but JH rejected it. She was referred by the 
neurologist to a psychologist for group therapy. After a few sessions, JH quit her therapy because 
she felt her symptoms did not decrease.
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2.2. Presentation at our centre
JH presented herself at the Clinical Centre of excellence for Body, Mind and Health, GGz Breburg 
(CLGG), Tilburg, the Netherlands in 2013. She reported severe subjective neurocognitive symptoms in 
both memory and attention, leading to inactivity and fatigue, which became obvious by her missing 
appointments that she had failed to remember. She experienced continuous pain in the occipital 
region of her head and in the entire left part of her body. The pain worsened when she became more 
fatigued. At presentation, the patient stuttered and talked with slurred speech. Physical examina-
tion did not show any neurological or other abnormalities. After psychiatric examination, the patient 
was diagnosed with CD.
2.3. Lab results
Lab results of patient JH, exploring hemoglobin level, leukocytes, electrolytes, kidney function, cho-
lesterol, glucose, and Thyroid Stimulating Hormone, showed no abnormalities.
2.4. Neuropsychological assessment
At intake, a NPA was done to assess JH’s neurocognitive symptoms. The following domains were 
tested using the accompanying tests. Language was assessed using the Boston Naming Task 
(Heesbeen & van Loon-Vervoorn, 2001), verbal luency (Animal naming, 2 min), and letter luency 
(“N” and “A”, 1 min; Deelman, Koning-Haanstra, Liebrand, & van der Burg, 1981). Working memory 
was assessed by using the Digit Span of the Wechsler Adult Intelligence Scale—fourth edition 
(WAIS-IV; Wechsler, 2008), verbal memory by the Rey Auditory Verbal Learning Test (RAVLT; Saan & 
Deelman, 1986), and the Rivermead Behavioural Memory Test (RBMT; Wilson, Cockburn, & Baddely, 
1985) and visual memory with the Rey Osterrieth Complex Figure Test (ROCFT; Osterrieth, 1944). 
Information processing speed was measured by the Symbol Substitution subtest of the WAIS-IV 
(Wechsler, 2008), Trail Making Test part A (TMT-A; Reitan, 1992), and the Stroop Color-Word test part 
I and II (Jensen, 1965; Stroop, 1935). Within the domain of attention, inhibition was assessed using 
part III of the Stroop Color-Word test (Stroop, 1935) (while controlling for the scores on part I and II 
of the Stroop), divided attention using the TMT-B (while controlling for performance on TMT-A) and 
sustained attention using the d2-test (Brickenkamp, 2002). EF was explored using three subtests of 
the Behavioural Assessment of the Dysexecutive Syndrome (BADS; Wilson, Alderman, Burgess, 
Emslie, & Evans, 1996), namely the Key search, Zoo map, and Rule learning Task for assessing, re-
spectively, planning, (complex) planning, and rule learning. Malingering was assessed using the Test 
of Memory Malingering (TOMM; Tombaugh, 1996).
A selection of tests was repeated after treatment with TPM (referred to as T4; the time between T0 
and T4 was six months). Parallel tests were used in this NPA when possible, namely for the RAVLT 
and the ROCFT. With regard to the ROCFT, the parallel Modiied Taylor Complex Figure Test (MTCF) 
(Lezak, Howieson, & Loring, 2004) version was used. All test scores were compared to available 
 normative scores, taking into account age, gender, and educational level.
In order to make use of TPM, Winkens and Fasotti (2010) suggest the use of at least one measure-
ment of mental slowness to assess neurocognitive impairment in this domain during NPA. In this 
study, we used three measures of mental slowness to assess mental slowness during the NPA: the 
Symbol substitution subtest of the WAIS-IV, TMT-A, and parts I and II of the Stroop Color-Word Test. 
The results for the NPA prior and after treatment are shown in Table 1.
NPA at intake showed impaired scores (scores below 6th percentile compared to healthy norms) 
within the domains of sustained attention, working memory, divided attention, and information pro-
cessing speed. Furthermore, di culties (scores below 16th percentile compared to healthy norms) 
were found in the domains of visual and verbal memory and planning. No signs of malingering were 
found. During the anamnesis, patient JH reported that she needed more time to achieve subjective 
normal performances and that she “got lost” when she received a substantial amount of informa-
tion. These symptoms and neurocognitive impairments resulted in signiicant fatigue, which led to 
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inactivity. Patient JH told that she was unable to perform household activities or practice sports, 
something she enjoyed doing before.
After TPM, impairment of information processing speed, working memory, visual/verbal memory, 
and divided attention dissolved. Patient JH was still impaired with regard to information processing 
speed, based on her verbal reaction during parts I and II of the Stroop Color-Word Test. Based on 
part III of the Stroop Color-Word Test, she also experienced di culties within the domain of atten-
tion (inhibition). No signs of malingering were found, as assessed by the TOMM.
2.5. Questionnaire assessments
At CLGG, patients are monitored during treatment using Routine Outcome Monitoring (ROM) embed-
ded in a shared decision-making model (Van der Feltz-Cornelis, Andrea, et al., 2014). At intake, they 
ill in a complete assessment that includes the Patient Health Questionnaire 9 (PHQ-9) that meas-
ures depression and is a reliable questionnaire (coeicient alpha = .89) (Kroenke, Spitzer, & Williams, 
2001), the General Anxiety Disorder-7 (GAD-7) that is considered a reliable questionnaire (coeicient 
Table 1. JH’s performance on the NPA
*≤16th percentile.
**≤6th percentile compared with normative data.
aParallel versions for the RAVLT and ROCFT are used.
bROCFT was used at T0, MTCF was used at T4.
Neurocognitive domain Test Score at T0 Score at T4a
Language BNT 166/175
Animal naming 37
Letter luency (N + A) 16
Working memory Digit span 17** 22
Memory RAVLT
 Immediate recall 37* 38
 Delayed recall 6/15** 7/15
 Recognition 28/30 29/30
RBMT
 Immediate recall 12.5*
 Delayed recall 9.5**
ROCFT/MTCFb
 Immediate recall 10* 29
 Delayed recall 9** 29
Information processing speed TMT-A 34 46
Symbol substitution 37** 47
Stroop
 Part I 86** 64**
 Part II 120* 79**
Attention TMT-B 129** 65
Stroop
 Part III 176 154*
d2 26**
Executive functioning Rule learning 4
Key search test 3
Zoo map test 2
Malingering TOMM 50/50 50/50
Page 6 of 12
de Vroege et al., Cogent Psychology (2017), 4: 1348328
https://doi.org/10.1080/23311908.2017.1348328
alpha = .92) for measuring anxiety (Spitzer, Kroenke, Williams, & Löwe, 2006), the Patient Health 
Questionnaire 15 (PHQ-15) a reliable questionnaire (coeicient alpha = .80) (Kroenke, Spitzer, 
Williams, & Löwe, 2010) that measures somatic symptoms (Kroenke, Spitzer, & Williams, 2002), the 
Physical Symptoms Questionnaire (Dutch abbreviation: LKV) that measures physical symptoms (co-
eicient alpha = .88) (Van Hemert, 2003), the Brief Pain Inventory (BPI) that reliably measures pain 
(coeicient alpha = .85) (Tan, Jensen, Thornby, & Shanti, 2004), and the Outcome Questionnaire (OQ; 
Lambert et al., 2004) that is designed for repeated measurements of client progress while in therapy 
(coeicient alpha = .91) (de Jong et al., 2007). A selection of questionnaires is based on the outcome 
of a shared decision-making process with the patient and the clinician and is established during a 
multidisciplinary meeting. Table 2 shows the scores on the ROM questionnaires at intake and after 
TPM.
At intake, the ROM scores show high scores on PHQ-15, PHQ-9, and LKV, which indicate, respec-
tively, present somatic symptoms, depression, and physical symptoms. Furthermore, the GAD-7 
score is indicative of the absence of anxiety. BPI score of 5 is indicative of the presence of pain during 
the past week. The OQ (Lambert et al., 2004) is used to measure the outcome of treatment and was 
93 at intake. After TPM, the scores of OQ, PHQ-9, LKV, and BPI were substantially lower. In order to 
monitor improvement during treatment, the patient was asked to ill out selected questionnaires to 
monitor their improvement from the start of treatment (T1) until the end of TPM treatment (T4). In 
this case, because of her various physical symptoms, JH was asked to ill out the LKV (Van Hemert, 
2003) to monitor physical symptomatology during the course of treatment.
Furthermore, to assess mental slowness subjectively, the Mental Slowness Questionnaire (MSQ; 
Winkens, Van Heugten, Fasotti, et al., 2009) was used as suggested in the protocol (Winkens & 
Fasotti, 2010). The MSQ consists of 21 items exploring problems with engaging in activities which are 
related to mental slowness. For instance, “I can’t follow a story when I listen to the radio or watch 
TV at the same time” or “It takes me more time to execute work, choir or household activities be-
cause I have to think about them more.” Each item is scored on a ive-point scale ranging from 0 to 
4. Answering options correspond to the frequency of experiencing the complaint (0: this never hap-
pens, 1: this happens occasionally, 2: this happens now and then, 3: this happens regularly, 4: this 
happens often). The maximum score of this subscale is 84 (21 × 4). A severity score is also given for 
each item on a three-point scale with answers ranging from “Not troublesome,” “A little bit trouble-
some” to “Very troublesome,” scored 0, 1, and 2, respectively. The maximum score of this subscale 
is 42 (21 × 2). To conclude, a weighted scale can be calculated by multiplying the score of the fre-
quency scale with that of the severity scale. The maximum score of this weighted subscale is 168 
(score on di culty scale, multiplied by scale of severity, multiplied by the number of questions; that 
is, 4 × 2 × 21).
At the start of TPM, JH scored 85 on the LKV (physical symptoms were apparent at intake). At T2 
and T3, the LKV scores were 84 and 87, respectively. At the end of treatment (T4), the LKV score was 
47, which indicates a decrease of 15 in experienced physical symptoms.
Table 2. ROM questionnaires at intake and after TPM
Abbreviations: OQ: Outcome Questionnaire; PHQ: Patient Health Questionnaire; GAD: General Anxiety Disorder; LKV 
(Dutch abbreviation): Physical Symptoms Questionnaire; BPI: Brief Pain Inventory.
Questionnaire Scores at intake Scores after TPM
OQ 93 75
PHQ-15 8
PHQ-9 11 7
GAD-7 5
LKV 85 47
BPI 5 3
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At T1, the MSQ frequency score was 79, the MSQ severity score was 42, and the weighted scale of 
frequency and severity scale was 158. After treatment at T4, all scores decreased substantially to a 
score of 57 on the MSQ frequency, MSQ severity score dropped to 14 and the score on the MSQ 
weighted scale was 38. Figure 1 represents the scores on the LKV and MSQ over time during TPM.
2.6. Intervention—Neuropsychological treatment
The TPM strategy includes enhancement of awareness, optimization of organization, rehearsal of 
task requirement, or modiication of task environment. These concrete tools are learnt by the pa-
tient in three stages. The irst stage focuses primarily on increasing awareness of the deicits and the 
relationship between mental slowness and perceived problems in daily life. In the second stage, the 
main focus is on acceptance and acquisition of the strategy. Besides relating the (poor) performance 
of the patient and the concept of time pressure, the strategy was explained and taught to the pa-
tient. The inal stage focuses on strategy application and maintenance. This stage mainly involves 
real-life application of the strategy by the patient, evaluating the results of its application and im-
proving the strategy during the treatment session. TPM training in patients with closed head injuries 
and stroke already appeared to be more beneicial compared to other kinds of training and general-
izes to measures of memory and speed function (Winkens, Van Heugten, Wade, Habets, & Fasotti, 
2009). Table 3 describes the cognitive strategy used in TPM.
Table 3. The cognitive strategy in TPM
Source: Extracted with permission from Fasotti et al. (2000).
Questions to be asked Main objective to be taught
1. Are there two or more things to be done at the same 
time for which there is not enough time? If yes: go to 
step 2, else just do the task
To recognize time pressure in the task at hand
2. Make a short plan of which things can be done before 
the actual task begins
To prevent as much time pressure as possible
3. Make an emergency plan describing what to do in case 
of overwhelming time pressure
Dealing with time pressure as quickly and efectively as 
possible
4. Plan and emergency plan ready? Then use it regularly Urging the patient to monitor him/herself while using the 
TPM strategy
Figure 1. Scores on the LKV and 
MSQ over time during TPM.
Abbreviations: LKV (Dutch 
abbreviation): Physical 
Symptom Questionnaire; 
MSQ: Mental Slowness 
Questionnaire; freq.; frequency; 
sev.: severity; weight.: 
weighted.  
Note: MSQ is not assessed 
during T2 and T3.
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2.7. Questionnaire assessments—Treatment course and outcome
After gaining awareness of the situation, during the irst stage of TPM, JH learned that mental slow-
ness inluenced her life more than she had previously realized. After successfully learning TPM and 
applying the strategy in real life, JH experienced less frequent and less severe subjective neurocogni-
tive symptoms.
After the last session of TPM, JH described experiencing pain one day every week. This pain was 
manageable and only limited her in activities that she still found more stressful, for instance, visiting 
friends in a crowded place. However, she explained being able to visit crowded parties, which she 
had not been capable of doing before, and stated “I can have control over my life once again.” JH 
also started to exercise again, although setting boundaries was sometimes still troublesome. 
Pushing boundaries still resulted in inactivity the next day, but these days decreased in number 
substantially and recovery speeded up compared to pre-treatment. With regard to the acquired TPM 
strategy, JH stated that she noticed when she had not optimally applied the strategy. JH reported 
being able to successfully adjust her behavior to a particular situation and to handle the situation 
with less mental slowness and stress.
JH also stated being able to cope with mental slowness and to apply the strategy in daily life to 
overcome hindrances caused by mental slowness, which was conirmed by the decreased MSQ 
scores after treatment. The improvement in aforementioned neurocognitive symptoms was con-
irmed with a NPA post-treatment that showed improvements in mental slowness, divided atten-
tion, and (working) memory. With regard to the information processing of verbal information (Stroop 
I and II), these did not improve. This can be explained by JH’s slurred speech and stuttering during 
conversations, which were still present post-treatment. Also, inhibition remained impaired at T4. 
With regard to the ROM, physical symptoms decreased after TPM. JH started to regain her life and 
was better able to participate in daily life activities compared to pre-treatment.
2.8. Evaluation of treatment and diagnosis
JH told us during intake that she felt mistreated and misunderstood by medical professionals she 
had seen before during the assessment at the neurological clinic (with negative results on, for in-
stance, the CT scan and MRI) and by the conclusion of the neurologist that her symptoms could be 
explained as psychogenic. Prior to the start of the neuropsychological treatment, the NPA results 
gave the clinician the opportunity to discuss neurocognitive impairment and thus conirm JH’s sub-
jective neurocognitive complaints. Later on, in the irst stage of the neuropsychological treatment, 
the present neurocognitive impairment without organic substrate gave the clinician the opportunity 
to discuss the negative results of the MRI in relation to the objectiied neurocognitive impairment. 
We provided JH an explanation stating that since the MRI conirmed no organic substrate, yet the 
NPA had conirmed impairment was present, these neurocognitive functions could be used in treat-
ment to retrain these cognitive brain functions and ultimately decrease the neurocognitive impair-
ment she sufered from. This explanation also opened up the opportunity to discuss the diagnosis of 
CD. As a result, JH felt understood and taken seriously, as she explained afterward. Within our shared 
decision-making process, we then ofered her the opportunity to see a psychologist for cognitive 
behavioral therapy (CBT) aimed at fatigue since she still reported sufering from fatigue.
3. Discussion
3.1. Key results
JH sufered from CD with mixed symptoms, including many physical symptoms (such as pain). She 
also sufered from mental slowness and impaired working memory and attention at a symptomatic 
level. These symptoms led to inactivity and she had great di culty functioning in daily life. 
Furthermore, she experienced memory problems and fatigue after (mental) efort that severely in-
terfered with her social life, for instance, when visiting friends. After TPM, she reported being able to 
participate in daily life and her physical symptoms, as well as neurocognitive impairment, improved. 
The CD went into remission.
Page 9 of 12
de Vroege et al., Cogent Psychology (2017), 4: 1348328
https://doi.org/10.1080/23311908.2017.1348328
3.2. Additional results
The use of a NPA enabled the clinicians to explain neurocognitive impairment without organic cause 
to a patient that has felt misunderstood for three years. The combination of the negative results on 
prior neurological assessments and the results of the NPA allowed the clinician to provide the patient 
with a framework and explanation for her symptoms. It also enabled the clinician to provide an out-
line of therapy in which rehabilitation of brain function was the central feature. In this way, the pa-
tient felt understood, leading to increased self-conidence and commitment. It also contributed to an 
improved relationship with the clinicians at our clinic, enabling them to discuss the diagnosis of CD.
3.3. Comparison to the literature
This is the irst case report describing treatment of mental slowness in CD using TPM. Not only neu-
rocognitive impairment but also somatic symptoms improved, which suggests an association be-
tween neurocognitive impairment, feeling ill, and the experience of somatic symptoms, stress, or 
pain in CD. A NPA can serve as a conirmation of these subjective neurocognitive symptoms. 
Therefore, clinicians are advised to use NPA to assess these symptoms in patients with CD. 
Furthermore, these neurocognitive impairments can serve as a framework for treatment. This opens 
an alternative avenue for treatment of CD that may be very welcome, especially because few suc-
cessful treatment options are known for CD (Kroenke, 2007).
When memory problems are present, CRT designed for memory problems can be used to overcome 
these symptoms in the context of a neuropsychological treatment (Hendriks, Kessels, Gorissen, 
Schmand, & Duits, 2014; Ponds, van Heugten, Fasotti, & Wekking, 2010). One can argue that CBT, the 
treatment of choice (Kroenke, 2007), can be negatively inluenced by such neurocognitive problems. In 
particular, memory problems that are followed by impairment in information processing speed might 
interfere with therapy since these patients might forget appointments and homework. In this way, 
memory problems interfere with CBT and the adaptation of a cognitive strategy to overcome these 
impairments can be of added value before and during CBT sessions. Furthermore, one can argue that 
through using TPM, the planning capacity of patients is also improved since the cognitive strategy in-
corporates a restructuring of actions (see Table 3) in situations where mental speed is necessary. If this 
is the case, planning problems may also play a role in the pathogenesis of CD. In this way, the need to 
explore and implement personalized types of treatments has been stressed (Schumann et al., 2014; 
Van der Feltz-Cornelis, Van Os, et al., 2014). This case report shows that a tailor-made treatment can be 
selected based on a speciic patient’s neurocognitive proile, even if this is not based on brain injury but 
on psychological causes, as with CD, and that such a tailor-made treatment for CD can be beneicial.
3.4. Strengths and limitations
This is the irst study exploring the use of TPM in patients with CD, and this innovative approach is a 
strength of the study. Another strength of this study is the inclusion of a malingering test in the NPA. 
Since the results of this test did not indicate malingering, it can be stated that cognition does appear 
to be genuinely impaired, despite the lack of organic substrate. The use of ROM is also a strength of 
this study, since it enabled us to monitor physical symptoms during the course of treatment. It 
showed us that physical symptomatology decreased as treatment continued, something which JH 
airmed during the sessions. The use of the MSQ before and after treatment is also a strength of this 
study, as this enabled us to explore the consequences of mental slowness in daily life (rather than 
only in idealized circumstances, as is the case with the NPA) (Winkens, van Heugten, Fasotti, & Wade, 
2011) and to assess the treatment efects at T4 in an objective manner. Finally, the use of a NPA 
after treatment allows us to conirm improvement of JH’s subjective neurocognitive symptoms and 
therefore can be considered as a strength of this study as well.
One limitation of this study is the use of the same neuropsychological tests at T4 and T0. Although 
parallel versions of neuropsychological tests were used as much as possible, the neuropsychological 
measures at T4 might be inluenced by practice efects, since JH was already familiar with some of 
the test structures used at T0. Furthermore, the NPA at T4 did not include parallel tests related to 
planning, so conclusions about improved planning capacities could not be drawn.
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Since this is a single case report study, caution should also be exercised with regard to the conclu-
sion of this study. The improvement might have relected the natural course of her condition; how-
ever, this seems improbable, as the patient had sufered from her condition for three years when she 
visited our center, despite previous treatments. Also, as should be obvious, the positive results of a 
case study cannot be considered generalizable per se. Nevertheless, this study does provide clini-
cally relevant outcomes that warrant further research.
Although our patient’s fatigue and cognitive impairment could have been related to myalgic en-
cephalomyelitis (Carruthers et al., 2011), our patient did not fulill the other criteria for this condition. 
Therefore, we can conclude with certainty that our patient had a CD. One might argue that our pa-
tient sufered from neural inlammation, apoptosis, or other related issues consistent with brain in-
fection of some types, but since our patient improved during treatment these options do not apply. 
Therefore, we had no rationale for including additional tests such as electroencephalogram or 
magnetoencephalography.
3.5. Implications for research
Future studies should focus on adapting CRT for treatment of a speciic neurocognitive symptom in 
patients with CD, based on the results of a NPA. This enables clinicians to tailor a treatment based on 
patient proiles which can maximize improvement (Laatsch & Stress, 2000). Also, future studies 
should explore the eicacy of tailor-made CRTs in patients with CD compared to usual treatments 
(medication and/or cognitive behavioral therapy for instance) in RCTs. Researchers should include 
parallel versions for each neurocognitive domain that is tested before and after treatment. This al-
lows researchers to draw conclusions for all domains and not just a selection of domains.
The etiology of CD remains unclear. Neuroimaging studies might shed new light on the origin of 
CD. The results of this case study show that impairment in neurocognitive functioning improves after 
treatment, which suggest alterations on a neurobiological level and altered brain activity after treat-
ment. Brain alterations have been found by several studies (de Lange, Toni, & Roelofs, 2010; Ejareh 
dar & Kanaan, 2016; Feinstein, 2011; Voon et al., 2010; Vuilleumier, 2005). Although these studies 
are diverse in terms of methodology, they are included relatively small samples and showed difer-
ent results a recent review concludes that the majority of these studies showed abnormalities in 
emotion processing and emotion-motor processing (Ejareh dar & Kanaan, 2016). Although in its in-
fancy, fMRI studies provide insight into the etiology of CD and allow the construction of a model for 
CD. Future studies should therefore include pre-treatment fMRI, pre-treatment NPA, followed by 
tailor-made CRT, and post-treatment NPA and fMRI. In this way, a theoretical model for CD can be 
explored and the efectiveness of CRT in CD patients can be determined.
4. Conclusion
This case report describes a patient with CD with mixed symptoms, mental slowness and other neu-
rocognitive symptoms as well as inactivity. After CRT for mental slowness, the severity of both neu-
rocognitive impairment and the somatic symptoms improved, the CD dissolved, and the patient 
could resume her daily activities. This suggests that CRT can be a treatment option for CD with 
neurocognitive symptoms. Further research into the eicacy of tailor-made CRTs by RCTs in patients 
with CD should be conducted. Additionally, fMRI studies should be continued to explore the role of 
brain activity in improved neurocognitive functioning in CD.
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